Mail-Back Envelopes Will Be Dispensed With Outpatient Opioid Scripts
The FDA will require manufacturers of opioid drugs that are dispensed in outpatient settings to provide prepaid mail-back envelopes to outpatient pharmacies and other dispensers, the agency announced Monday. The move is part of the FDA’s comprehensive approach to addressing the overdose crisis, according to FDA Commissioner Robert Califf, MD. “We believe these efforts will …
Mail-Back Envelopes Will Be Dispensed With Outpatient Opioid Scripts Read More »








